<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2017-11-22" version="212">
<accession>P00813</accession>
<accession>Q53F92</accession>
<accession>Q6LA59</accession>
<name>ADA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Adenosine deaminase</fullName>
<ecNumber evidence="13 19 31">3.5.4.4</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Adenosine aminohydrolase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">ADA</name>
<name type="synonym">ADA1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1984" name="J. Biol. Chem." volume="259" first="12101" last="12106">
<title>Human adenosine deaminase. cDNA and complete primary amino acid sequence.</title>
<authorList>
<person name="Daddona P.E."/>
<person name="Shewach D.S."/>
<person name="Kelley W.N."/>
<person name="Argos P."/>
<person name="Markham A.F."/>
<person name="Orkin S.H."/>
</authorList>
<dbReference type="PubMed" id="6090454"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1984" name="Nucleic Acids Res." volume="12" first="2439" last="2446">
<title>Sequence of human adenosine deaminase cDNA including the coding region and a small intron.</title>
<authorList>
<person name="Wiginton D.A."/>
<person name="Adrian G.S."/>
<person name="Hutton J.J."/>
</authorList>
<dbReference type="PubMed" id="6546794"/>
<dbReference type="DOI" id="10.1093/nar/12.5.2439"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1985" name="EMBO J." volume="4" first="437" last="443">
<title>Adenosine deaminase: characterization and expression of a gene with a remarkable promoter.</title>
<authorList>
<person name="Valerio D."/>
<person name="Duyvesteyn M.G.C."/>
<person name="Dekker B.M.M."/>
<person name="Weeda G."/>
<person name="Berkvens T.M."/>
<person name="van der Voorn L."/>
<person name="van Ormondt H."/>
<person name="van der Eb A.J."/>
</authorList>
<dbReference type="PubMed" id="3839456"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1986" name="Biochemistry" volume="25" first="8234" last="8244">
<title>Complete sequence and structure of the gene for human adenosine deaminase.</title>
<authorList>
<person name="Wiginton D.A."/>
<person name="Kaplan D.J."/>
<person name="States J.C."/>
<person name="Akeson A.L."/>
<person name="Perme C.M."/>
<person name="Bilyk I.J."/>
<person name="Vaughn A.J."/>
<person name="Lattier D.L."/>
<person name="Hutton J.J."/>
</authorList>
<dbReference type="PubMed" id="3028473"/>
<dbReference type="DOI" id="10.1021/bi00373a017"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Thymus</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2004-08" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-11</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>B-cell lymphoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1983" name="J. Biol. Chem." volume="258" first="12753" last="12756">
<title>Molecular cloning of human adenosine deaminase gene sequences.</title>
<authorList>
<person name="Orkin S.H."/>
<person name="Daddona P.E."/>
<person name="Shewach D.S."/>
<person name="Markham A.F."/>
<person name="Bruns G.A."/>
<person name="Goff S.C."/>
<person name="Kelley W.N."/>
</authorList>
<dbReference type="PubMed" id="6688808"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 141-363</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1993" name="Biochem. J." volume="290" first="457" last="462">
<title>Demonstration of adenosine deaminase activity in human fibroblast lysosomes.</title>
<authorList>
<person name="Lindley E.R."/>
<person name="Pisoni R.L."/>
</authorList>
<dbReference type="PubMed" id="8452534"/>
<dbReference type="DOI" id="10.1042/bj2900457"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1993" name="Science" volume="261" first="466" last="469">
<title>Direct association of adenosine deaminase with a T cell activation antigen, CD26.</title>
<authorList>
<person name="Kameoka J."/>
<person name="Tanaka T."/>
<person name="Nojima Y."/>
<person name="Schlossman S.F."/>
<person name="Morimoto C."/>
</authorList>
<dbReference type="PubMed" id="8101391"/>
<dbReference type="DOI" id="10.1126/science.8101391"/>
</citation>
<scope>INTERACTION WITH DPP4</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1994" name="Eur. J. Immunol." volume="24" first="566" last="570">
<title>Binding of adenosine deaminase to the lymphocyte surface via CD26.</title>
<authorList>
<person name="De Meester I."/>
<person name="Vanham G."/>
<person name="Kestens L."/>
<person name="Vanhoof G."/>
<person name="Bosmans E."/>
<person name="Gigase P."/>
<person name="Scharpe S."/>
</authorList>
<dbReference type="PubMed" id="7907293"/>
<dbReference type="DOI" id="10.1002/eji.1830240311"/>
</citation>
<scope>INTERACTION WITH DPP4</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Eur. J. Biochem." volume="267" first="5608" last="5613">
<title>Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.</title>
<authorList>
<person name="Durinx C."/>
<person name="Lambeir A.M."/>
<person name="Bosmans E."/>
<person name="Falmagne J.B."/>
<person name="Berghmans R."/>
<person name="Haemers A."/>
<person name="Scharpe S."/>
<person name="De Meester I."/>
</authorList>
<dbReference type="PubMed" id="10951221"/>
<dbReference type="DOI" id="10.1046/j.1432-1327.2000.01634.x"/>
</citation>
<scope>INTERACTION WITH DPP4</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="Biochem. J." volume="361" first="203" last="209">
<title>Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction.</title>
<authorList>
<person name="Gines S."/>
<person name="Marino M."/>
<person name="Mallol J."/>
<person name="Canela E.I."/>
<person name="Morimoto C."/>
<person name="Callebaut C."/>
<person name="Hovanessian A."/>
<person name="Casado V."/>
<person name="Lluis C."/>
<person name="Franco R."/>
</authorList>
<dbReference type="PubMed" id="11772392"/>
<dbReference type="DOI" id="10.1042/0264-6021:3610203"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="20993" last="20998">
<title>Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells.</title>
<authorList>
<person name="Gonzalez-Gronow M."/>
<person name="Hershfield M.S."/>
<person name="Arredondo-Vega F.X."/>
<person name="Pizzo S.V."/>
</authorList>
<dbReference type="PubMed" id="15016824"/>
<dbReference type="DOI" id="10.1074/jbc.M401023200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DPP4 AND PLG</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="145" last="154">
<title>N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.</title>
<authorList>
<person name="Aertgeerts K."/>
<person name="Ye S."/>
<person name="Shi L."/>
<person name="Prasad S.G."/>
<person name="Witmer D."/>
<person name="Chi E."/>
<person name="Sang B.C."/>
<person name="Wijnands R.A."/>
<person name="Webb D.R."/>
<person name="Swanson R.V."/>
</authorList>
<dbReference type="PubMed" id="14691230"/>
<dbReference type="DOI" id="10.1110/ps.03352504"/>
</citation>
<scope>INTERACTION WITH DPP4</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Blood" volume="108" first="1602" last="1610">
<title>Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26.</title>
<authorList>
<person name="Eltzschig H.K."/>
<person name="Faigle M."/>
<person name="Knapp S."/>
<person name="Karhausen J."/>
<person name="Ibla J."/>
<person name="Rosenberger P."/>
<person name="Odegard K.C."/>
<person name="Laussen P.C."/>
<person name="Thompson L.F."/>
<person name="Colgan S.P."/>
</authorList>
<dbReference type="PubMed" id="16670267"/>
<dbReference type="DOI" id="10.1182/blood-2006-02-001016"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INDUCTION BY HYPOXIA</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-54 AND LYS-232</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="J. Leukoc. Biol." volume="89" first="127" last="136">
<title>Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells.</title>
<authorList>
<person name="Martinez-Navio J.M."/>
<person name="Casanova V."/>
<person name="Pacheco R."/>
<person name="Naval-Macabuhay I."/>
<person name="Climent N."/>
<person name="Garcia F."/>
<person name="Gatell J.M."/>
<person name="Mallol J."/>
<person name="Gallart T."/>
<person name="Lluis C."/>
<person name="Franco R."/>
</authorList>
<dbReference type="PubMed" id="20959412"/>
<dbReference type="DOI" id="10.1189/jlb.1009696"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2012" name="Andrologia" volume="44" first="586" last="589">
<title>Adenosine deaminase activity in fertile and infertile men.</title>
<authorList>
<person name="Rostampour F."/>
<person name="Biglari M."/>
<person name="Vaisi-Raygani A."/>
<person name="Salimi S."/>
<person name="Tavilani H."/>
</authorList>
<dbReference type="PubMed" id="21919946"/>
<dbReference type="DOI" id="10.1111/j.1439-0272.2011.01231.x"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="FASEB J." volume="27" first="1048" last="1061">
<title>The catalytic site structural gate of adenosine deaminase allosterically modulates ligand binding to adenosine receptors.</title>
<authorList>
<person name="Gracia E."/>
<person name="Farre D."/>
<person name="Cortes A."/>
<person name="Ferrer-Costa C."/>
<person name="Orozco M."/>
<person name="Mallol J."/>
<person name="Lluis C."/>
<person name="Canela E.I."/>
<person name="McCormick P.J."/>
<person name="Franco R."/>
<person name="Fanelli F."/>
<person name="Casado V."/>
</authorList>
<dbReference type="PubMed" id="23193172"/>
<dbReference type="DOI" id="10.1096/fj.12-212621"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>MUTAGENESIS OF LEU-58; ASP-60; PHE-61; LEU-62; LYS-64; PHE-65; ASP-66; MET-69; ILE-115; ASN-118; MET-155; HIS-157; GLY-184; ASP-185 AND LEU-194</scope>
</reference>
<reference key="24">
<citation type="submission" date="2009-08" db="PDB data bank">
<title>The crystal structure of human adenosine deaminase.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.52 ANGSTROMS) OF 5-363 IN COMPLEX WITH NICKEL IONS AND 2-DEAOXYADENOSINE</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="6171" last="6175">
<title>Hot spot mutations in adenosine deaminase deficiency.</title>
<authorList>
<person name="Hirschhorn R."/>
<person name="Tzall S."/>
<person name="Ellenbogen A."/>
</authorList>
<dbReference type="PubMed" id="2166947"/>
<dbReference type="DOI" id="10.1073/pnas.87.16.6171"/>
</citation>
<scope>VARIANTS ADASCID TRP-76; PRO-107; GLN-149; CYS-211; THR-215 AND LEU-274</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1994" name="Ann. Hum. Genet." volume="58" first="1" last="9">
<title>An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): occurrence on different chromosomal backgrounds and apparent intragenic crossover.</title>
<authorList>
<person name="Hirschhorn R."/>
<person name="Yang D.R."/>
<person name="Israni A."/>
</authorList>
<dbReference type="PubMed" id="8031011"/>
<dbReference type="DOI" id="10.1111/j.1469-1809.1994.tb00720.x"/>
</citation>
<scope>VARIANT ADA*2 ASN-8</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1984" name="Mol. Cell. Biol." volume="4" first="1712" last="1717">
<title>Structure of adenosine deaminase mRNAs from normal and adenosine deaminase-deficient human cell lines.</title>
<authorList>
<person name="Adrian G.S."/>
<person name="Wiginton D.A."/>
<person name="Hutton J."/>
</authorList>
<dbReference type="PubMed" id="6208479"/>
<dbReference type="DOI" id="10.1128/MCB.4.9.1712"/>
</citation>
<scope>VARIANTS ADASCID</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1985" name="J. Clin. Invest." volume="76" first="894" last="897">
<title>Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.</title>
<authorList>
<person name="Bonthron D.T."/>
<person name="Markham A.F."/>
<person name="Ginsburg D."/>
<person name="Orkin S.H."/>
</authorList>
<dbReference type="PubMed" id="3839802"/>
<dbReference type="DOI" id="10.1172/JCI112050"/>
</citation>
<scope>VARIANT ADASCID GLN-101</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="16291" last="16296">
<title>Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts.</title>
<authorList>
<person name="Akeson A.L."/>
<person name="Wiginton D.A."/>
<person name="Dusing M.R."/>
<person name="States J.C."/>
<person name="Hutton J.J."/>
</authorList>
<dbReference type="PubMed" id="3182793"/>
</citation>
<scope>VARIANTS ADASCID TRP-101; HIS-211 AND VAL-329</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1989" name="J. Clin. Invest." volume="83" first="497" last="501">
<title>Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency.</title>
<authorList>
<person name="Hirschhorn R."/>
<person name="Tzall S."/>
<person name="Ellenbogen A."/>
<person name="Orkin S.H."/>
</authorList>
<dbReference type="PubMed" id="2783588"/>
<dbReference type="DOI" id="10.1172/JCI113909"/>
</citation>
<scope>VARIANT ADASCID GLN-297</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1992" name="Hum. Mutat." volume="1" first="166" last="168">
<title>Identification of two new missense mutations (R156C and S291L) in two ADA-SCID patients unusual for response to therapy with partial exchange transfusions.</title>
<authorList>
<person name="Hirschhorn R."/>
</authorList>
<dbReference type="PubMed" id="1284479"/>
<dbReference type="DOI" id="10.1002/humu.1380010214"/>
</citation>
<scope>VARIANTS ADASCID CYS-156 AND LEU-291</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1993" name="J. Clin. Invest." volume="92" first="2291" last="2302">
<title>Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.</title>
<authorList>
<person name="Santisteban I."/>
<person name="Arredondo-Vega F.X."/>
<person name="Kelly S."/>
<person name="Mary A."/>
<person name="Fischer A."/>
<person name="Hummell D.S."/>
<person name="Lawton A."/>
<person name="Sorensen R.U."/>
<person name="Stiehm E.R."/>
<person name="Uribe L."/>
<person name="Weinberg K."/>
<person name="Hershfield M.S."/>
</authorList>
<dbReference type="PubMed" id="8227344"/>
<dbReference type="DOI" id="10.1172/JCI116833"/>
</citation>
<scope>VARIANTS ADASCID LEU-101; HIS-156; MET-177; ARG-216 AND LEU-291</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1994" name="Clin. Immunol. Immunopathol." volume="70" first="171" last="175">
<title>Homozygosity for a missense mutation (G20R) associated with neonatal onset adenosine deaminase-deficient severe combined immunodeficiency (ADA-SCID).</title>
<authorList>
<person name="Yang D.R."/>
<person name="Huie M.L."/>
<person name="Hirschhorn R."/>
</authorList>
<dbReference type="PubMed" id="8299233"/>
<dbReference type="DOI" id="10.1006/clin.1994.1026"/>
</citation>
<scope>VARIANT ADASCID ARG-20</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="2081" last="2087">
<title>Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA.</title>
<authorList>
<person name="Santisteban I."/>
<person name="Arredondo-Vega F.X."/>
<person name="Kelly S."/>
<person name="Loubser M."/>
<person name="Meydan N."/>
<person name="Roifman C."/>
<person name="Howell P.L."/>
<person name="Bowen T."/>
<person name="Weinberg K.I."/>
<person name="Schroeder M.L."/>
<person name="Hershfield M.S."/>
</authorList>
<dbReference type="PubMed" id="8589684"/>
<dbReference type="DOI" id="10.1093/hmg/4.11.2081"/>
</citation>
<scope>VARIANTS ARG-80 AND GLN-142</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="5" first="243" last="250">
<title>Four new adenosine deaminase mutations, altering a zinc-binding histidine, two conserved alanines, and a 5' splice site.</title>
<authorList>
<person name="Santisteban I."/>
<person name="Arredondo-Vega F.X."/>
<person name="Kelly S."/>
<person name="Debre M."/>
<person name="Fisher A."/>
<person name="Perignon J.L."/>
<person name="Hilman B."/>
<person name="Eldahr J."/>
<person name="Dreyfus D.H."/>
<person name="Gelfand E.W."/>
<person name="Howell P.L."/>
<person name="Hershfield M.S."/>
</authorList>
<dbReference type="PubMed" id="7599635"/>
<dbReference type="DOI" id="10.1002/humu.1380050309"/>
</citation>
<scope>VARIANTS ADASCID ASP-15; ASP-83 AND ASP-179</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1997" name="Hum. Genet." volume="100" first="22" last="29">
<title>Two newly identified mutations (Thr233Ile and Leu152Met) in partially adenosine deaminase-deficient (ADA-) individuals that result in differing biochemical and metabolic phenotypes.</title>
<authorList>
<person name="Hirschhorn R."/>
<person name="Borkowsky W."/>
<person name="Jiang C.-K."/>
<person name="Yang D.R."/>
<person name="Jenkins T."/>
</authorList>
<dbReference type="PubMed" id="9225964"/>
<dbReference type="DOI" id="10.1007/s004390050460"/>
</citation>
<scope>VARIANTS MET-152 AND ILE-233</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1997" name="Hum. Mol. Genet." volume="6" first="2271" last="2278">
<title>An adenosine deaminase (ADA) allele contains two newly identified deleterious mutations (Y97C and L106V) that interact to abolish enzyme activity.</title>
<authorList>
<person name="Jiang C."/>
<person name="Hong R."/>
<person name="Horowitz S.D."/>
<person name="Kong X."/>
<person name="Hirschhorn R."/>
</authorList>
<dbReference type="PubMed" id="9361033"/>
<dbReference type="DOI" id="10.1093/hmg/6.13.2271"/>
</citation>
<scope>VARIANTS ADASCID CYS-97 AND VAL-106</scope>
<scope>CHARACTERIZATION OF VARIANTS ADASCID CYS-97; VAL-106; CYS-211 AND THR-215</scope>
<scope>CHARACTERIZATION OF VARIANT ILE-233</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="482" last="482">
<title>Seven novel mutations in the adenosine deaminase (ADA) gene in patients with severe and delayed onset combined immunodeficiency: G74C, V129M, G140E, R149W, Q199P, 462delG, and E337del.</title>
<authorList>
<person name="Arrendondo-Vega F.X."/>
<person name="Santisteban I."/>
<person name="Notarangelo L.D."/>
<person name="El Dahr J."/>
<person name="Buckley R."/>
<person name="Roifman C."/>
<person name="Conley M.E."/>
<person name="Hershfield M.S."/>
</authorList>
<dbReference type="PubMed" id="10200056"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1998)11:6&lt;482::AID-HUMU14>3.3.CO;2-8"/>
</citation>
<scope>VARIANTS ADASCID CYS-74; MET-129; GLU-140; TRP-149 AND PRO-199</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="15676" last="15681">
<title>A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans.</title>
<authorList>
<person name="Retey J.V."/>
<person name="Adam M."/>
<person name="Honegger E."/>
<person name="Khatami R."/>
<person name="Luhmann U.F.O."/>
<person name="Jung H.H."/>
<person name="Berger W."/>
<person name="Landolt H.-P."/>
</authorList>
<dbReference type="PubMed" id="16221767"/>
<dbReference type="DOI" id="10.1073/pnas.0505414102"/>
</citation>
<scope>EFFECT OF VARIANT ADA*2 ASN-8 ON SLEEP</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2008" name="Science" volume="321" first="1801" last="1806">
<title>Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.</title>
<authorList>
<person name="Jones S."/>
<person name="Zhang X."/>
<person name="Parsons D.W."/>
<person name="Lin J.C."/>
<person name="Leary R.J."/>
<person name="Angenendt P."/>
<person name="Mankoo P."/>
<person name="Carter H."/>
<person name="Kamiyama H."/>
<person name="Jimeno A."/>
<person name="Hong S.M."/>
<person name="Fu B."/>
<person name="Lin M.T."/>
<person name="Calhoun E.S."/>
<person name="Kamiyama M."/>
<person name="Walter K."/>
<person name="Nikolskaya T."/>
<person name="Nikolsky Y."/>
<person name="Hartigan J."/>
<person name="Smith D.R."/>
<person name="Hidalgo M."/>
<person name="Leach S.D."/>
<person name="Klein A.P."/>
<person name="Jaffee E.M."/>
<person name="Goggins M."/>
<person name="Maitra A."/>
<person name="Iacobuzio-Donahue C."/>
<person name="Eshleman J.R."/>
<person name="Kern S.E."/>
<person name="Hruban R.H."/>
<person name="Karchin R."/>
<person name="Papadopoulos N."/>
<person name="Parmigiani G."/>
<person name="Vogelstein B."/>
<person name="Velculescu V.E."/>
<person name="Kinzler K.W."/>
</authorList>
<dbReference type="PubMed" id="18772397"/>
<dbReference type="DOI" id="10.1126/science.1164368"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] GLN-142</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2012" name="Cereb. Cortex" volume="22" first="962" last="970">
<title>Functional ADA polymorphism increases sleep depth and reduces vigilant attention in humans.</title>
<authorList>
<person name="Bachmann V."/>
<person name="Klaus F."/>
<person name="Bodenmann S."/>
<person name="Schaefer N."/>
<person name="Brugger P."/>
<person name="Huber S."/>
<person name="Berger W."/>
<person name="Landolt H.P."/>
</authorList>
<dbReference type="PubMed" id="21734253"/>
<dbReference type="DOI" id="10.1093/cercor/bhr173"/>
</citation>
<scope>VARIANT ADA*2 ASN-8</scope>
<scope>CHARACTERIZATION OF VARIANT ASN-8</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2015" name="Urology" volume="86" first="730" last="734">
<title>The Role of G22 A Adenosine Deaminase 1 Gene Polymorphism and the Activities of ADA Isoenzymes in Fertile and Infertile Men.</title>
<authorList>
<person name="Fattahi A."/>
<person name="Khodadadi I."/>
<person name="Amiri I."/>
<person name="Latifi Z."/>
<person name="Ghorbani M."/>
<person name="Tavilani H."/>
</authorList>
<dbReference type="PubMed" id="26166670"/>
<dbReference type="DOI" id="10.1016/j.urology.2015.06.034"/>
</citation>
<scope>VARIANT ADA*2 ASN-8</scope>
<scope>CHARACTERIZATION OF VARIANT ASN-8</scope>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="4 5 8 11 13 15 18 19 20 31">Catalyzes the hydrolytic deamination of adenosine and 2-deoxyadenosine (PubMed:8452534, PubMed:16670267). Plays an important role in purine metabolism and in adenosine homeostasis. Modulates signaling by extracellular adenosine, and so contributes indirectly to cellular signaling events. Acts as a positive regulator of T-cell coactivation, by binding DPP4 (PubMed:20959412). Its interaction with DPP4 regulates lymphocyte-epithelial cell adhesion (PubMed:11772392). Enhances dendritic cell immunogenicity by affecting dendritic cell costimulatory molecule expression and cytokines and chemokines secretion (By similarity). Enhances CD4+ T-cell differentiation and proliferation (PubMed:20959412). Acts as a positive modulator of adenosine receptors ADORA1 and ADORA2A, by enhancing their ligand affinity via conformational change (PubMed:23193172). Stimulates plasminogen activation (PubMed:15016824). Plays a role in male fertility (PubMed:21919946, PubMed:26166670). Plays a protective role in early postimplantation embryonic development (By similarity).</text>
</comment>
<comment type="catalytic activity">
<text evidence="13 19 31">Adenosine + H(2)O = inosine + NH(3).</text>
</comment>
<comment type="cofactor">
<cofactor evidence="38">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text evidence="38">Binds 1 zinc ion per subunit.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="13 31">Inhibited by Cu(2+) and Hg(2+), coformycin, deoxycoformycin (dCF), 2-deoxyadenosine, 6-methylaminopurine riboside, 2-3-iso-propylidene-adenosine and erythro-9-(2-hydroxy-3-nonyl)adenine.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="31">37 uM for adenosine (at 25 degrees Celsius and pH 5.5)</KM>
<Vmax evidence="19">41 umol/min/mg enzyme</Vmax>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="7 10 11 26 28">Interacts with DPP4 (via extracellular domain) (PubMed:10951221, PubMed:14691230, PubMed:7907293, PubMed:8101391, PubMed:15016824). Interacts with PLG (via Kringle 4 domain); the interaction stimulates PLG activation when in complex with DPP4 (PubMed:15016824).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8 28">Cell membrane</location>
<topology>Peripheral membrane protein</topology>
<orientation>Extracellular side</orientation>
</subcellularLocation>
<subcellularLocation>
<location evidence="8">Cell junction</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="4">Cytoplasmic vesicle lumen</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="31">Lysosome</location>
</subcellularLocation>
<text evidence="8">Colocalized with DPP4 at the cell surface.</text>
</comment>
<comment type="tissue specificity">
<text evidence="15">Found in all tissues, occurs in large amounts in T-lymphocytes (PubMed:20959412). Expressed at the time of weaning in gastrointestinal tissues.</text>
</comment>
<comment type="induction">
<text evidence="13">Up-regulated by hypoxia.</text>
</comment>
<comment type="polymorphism">
<text evidence="12">There is a common allele, ADA*2, also known as the ADA 2 allozyme. It is associated with the reduced metabolism of adenosine to inosine. It specifically enhances deep sleep and slow-wave activity (SWA) during sleep.</text>
</comment>
<comment type="disease" evidence="6 9 16 21 22 23 24 25 29 30 34">
<disease id="DI-01016">
<name>Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency</name>
<acronym>ADASCID</acronym>
<description>An autosomal recessive disorder accounting for about 50% of non-X-linked SCIDs. SCID refers to a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients with SCID present in infancy with recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. ADA deficiency has been diagnosed in chronically ill teenagers and adults (late or adult onset). Population and newborn screening programs have also identified several healthy individuals with normal immunity who have partial ADA deficiency.</description>
<dbReference type="MIM" id="102700"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="37">Belongs to the metallo-dependent hydrolases superfamily. Adenosine and AMP deaminases family.</text>
</comment>
<comment type="online information" name="ADAbase">
<link uri="http://structure.bmc.lu.se/idbase/ADAbase/"/>
<text>ADA mutation db</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Adenosine_deaminase"/>
<text>Adenosine deaminase entry</text>
</comment>
<comment type="online information" name="Mendelian genes adenosine deaminase (ADA)">
<link uri="http://www.lovd.nl/ADA"/>
<text>Leiden Open Variation Database (LOVD)</text>
</comment>
<dbReference type="EC" id="3.5.4.4" evidence="13 19 31"/>
<dbReference type="EMBL" id="X02994">
<property type="protein sequence ID" value="CAA26734.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X02189">
<property type="protein sequence ID" value="CAA26130.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02190">
<property type="protein sequence ID" value="CAA26130.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02191">
<property type="protein sequence ID" value="CAA26130.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02192">
<property type="protein sequence ID" value="CAA26130.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02193">
<property type="protein sequence ID" value="CAA26130.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02194">
<property type="protein sequence ID" value="CAA26130.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02195">
<property type="protein sequence ID" value="CAA26130.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02196">
<property type="protein sequence ID" value="CAA26130.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02197">
<property type="protein sequence ID" value="CAA26130.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02198">
<property type="protein sequence ID" value="CAA26130.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02199">
<property type="protein sequence ID" value="CAA26130.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M13792">
<property type="protein sequence ID" value="AAA78791.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL139352">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z97053">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223397">
<property type="protein sequence ID" value="BAD97117.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007678">
<property type="protein sequence ID" value="AAH07678.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC040226">
<property type="protein sequence ID" value="AAH40226.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13335.1"/>
<dbReference type="PIR" id="A91032">
<property type="entry name" value="DUHUA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000013.2">
<property type="nucleotide sequence ID" value="NM_000022.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.654536"/>
<dbReference type="PDB" id="1M7M">
<property type="method" value="Model"/>
<property type="chains" value="A=1-363"/>
</dbReference>
<dbReference type="PDB" id="3IAR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="A=5-363"/>
</dbReference>
<dbReference type="PDBsum" id="1M7M"/>
<dbReference type="PDBsum" id="3IAR"/>
<dbReference type="ProteinModelPortal" id="P00813"/>
<dbReference type="SMR" id="P00813"/>
<dbReference type="BioGrid" id="106614">
<property type="interactions" value="22"/>
</dbReference>
<dbReference type="CORUM" id="P00813"/>
<dbReference type="DIP" id="DIP-371N"/>
<dbReference type="IntAct" id="P00813">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="MINT" id="MINT-5000852"/>
<dbReference type="STRING" id="9606.ENSP00000361965"/>
<dbReference type="BindingDB" id="P00813"/>
<dbReference type="ChEMBL" id="CHEMBL1910"/>
<dbReference type="DrugBank" id="DB07783">
<property type="generic name" value="1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB04218">
<property type="generic name" value="1-Deaza-Adenosine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00640">
<property type="generic name" value="Adenosine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00975">
<property type="generic name" value="Dipyridamole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00974">
<property type="generic name" value="Edetic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB05057">
<property type="generic name" value="Erdosteine"/>
</dbReference>
<dbReference type="DrugBank" id="DB02616">
<property type="generic name" value="FR117016"/>
</dbReference>
<dbReference type="DrugBank" id="DB02096">
<property type="generic name" value="FR221647"/>
</dbReference>
<dbReference type="DrugBank" id="DB03572">
<property type="generic name" value="FR230513"/>
</dbReference>
<dbReference type="DrugBank" id="DB03220">
<property type="generic name" value="FR233623"/>
</dbReference>
<dbReference type="DrugBank" id="DB02830">
<property type="generic name" value="FR236913"/>
</dbReference>
<dbReference type="DrugBank" id="DB03370">
<property type="generic name" value="FR239087"/>
</dbReference>
<dbReference type="DrugBank" id="DB01280">
<property type="generic name" value="Nelarabine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00552">
<property type="generic name" value="Pentostatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB04440">
<property type="generic name" value="Purine Riboside"/>
</dbReference>
<dbReference type="DrugBank" id="DB00277">
<property type="generic name" value="Theophylline"/>
</dbReference>
<dbReference type="DrugBank" id="DB00194">
<property type="generic name" value="Vidarabine"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1230"/>
<dbReference type="iPTMnet" id="P00813"/>
<dbReference type="PhosphoSitePlus" id="P00813"/>
<dbReference type="SwissPalm" id="P00813"/>
<dbReference type="BioMuta" id="ADA"/>
<dbReference type="DMDM" id="113339"/>
<dbReference type="EPD" id="P00813"/>
<dbReference type="MaxQB" id="P00813"/>
<dbReference type="PaxDb" id="P00813"/>
<dbReference type="PeptideAtlas" id="P00813"/>
<dbReference type="PRIDE" id="P00813"/>
<dbReference type="TopDownProteomics" id="P00813"/>
<dbReference type="DNASU" id="100"/>
<dbReference type="Ensembl" id="ENST00000372874">
<property type="protein sequence ID" value="ENSP00000361965"/>
<property type="gene ID" value="ENSG00000196839"/>
</dbReference>
<dbReference type="GeneID" id="100"/>
<dbReference type="KEGG" id="hsa:100"/>
<dbReference type="UCSC" id="uc002xmj.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="100"/>
<dbReference type="DisGeNET" id="100"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000196839.12"/>
<dbReference type="GeneCards" id="ADA"/>
<dbReference type="GeneReviews" id="ADA"/>
<dbReference type="HGNC" id="HGNC:186">
<property type="gene designation" value="ADA"/>
</dbReference>
<dbReference type="HPA" id="CAB004307"/>
<dbReference type="HPA" id="HPA001399"/>
<dbReference type="HPA" id="HPA023884"/>
<dbReference type="MalaCards" id="ADA"/>
<dbReference type="MIM" id="102700">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="608958">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P00813"/>
<dbReference type="OpenTargets" id="ENSG00000196839"/>
<dbReference type="Orphanet" id="39041">
<property type="disease" value="Omenn syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="277">
<property type="disease" value="Severe combined immunodeficiency due to adenosine deaminase deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA24503"/>
<dbReference type="eggNOG" id="KOG1097">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG1816">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00730000111151"/>
<dbReference type="HOGENOM" id="HOG000218816"/>
<dbReference type="HOVERGEN" id="HBG001718"/>
<dbReference type="InParanoid" id="P00813"/>
<dbReference type="KO" id="K01488"/>
<dbReference type="OMA" id="HHVGSAS"/>
<dbReference type="OrthoDB" id="EOG091G0NL8"/>
<dbReference type="PhylomeDB" id="P00813"/>
<dbReference type="TreeFam" id="TF314270"/>
<dbReference type="BioCyc" id="MetaCyc:HS02191-MONOMER"/>
<dbReference type="BRENDA" id="3.5.4.4">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-74217">
<property type="pathway name" value="Purine salvage"/>
</dbReference>
<dbReference type="SABIO-RK" id="P00813"/>
<dbReference type="SignaLink" id="P00813"/>
<dbReference type="ChiTaRS" id="ADA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P00813"/>
<dbReference type="GeneWiki" id="Adenosine_deaminase"/>
<dbReference type="GenomeRNAi" id="100"/>
<dbReference type="PRO" id="PR:P00813"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000196839"/>
<dbReference type="CleanEx" id="HS_ADA"/>
<dbReference type="ExpressionAtlas" id="P00813">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P00813">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030054">
<property type="term" value="C:cell junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060205">
<property type="term" value="C:cytoplasmic vesicle lumen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032839">
<property type="term" value="C:dendrite cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005764">
<property type="term" value="C:lysosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004000">
<property type="term" value="F:adenosine deaminase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001883">
<property type="term" value="F:purine nucleoside binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006154">
<property type="term" value="P:adenosine catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0046061">
<property type="term" value="P:dATP catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006157">
<property type="term" value="P:deoxyadenosine catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048566">
<property type="term" value="P:embryonic digestive tract development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002314">
<property type="term" value="P:germinal center B cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001821">
<property type="term" value="P:histamine secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043103">
<property type="term" value="P:hypoxanthine salvage"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046103">
<property type="term" value="P:inosine biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001889">
<property type="term" value="P:liver development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048286">
<property type="term" value="P:lung alveolus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060169">
<property type="term" value="P:negative regulation of adenosine receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042323">
<property type="term" value="P:negative regulation of circadian sleep/wake cycle, non-REM sleep"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002686">
<property type="term" value="P:negative regulation of leukocyte migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002906">
<property type="term" value="P:negative regulation of mature B cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070256">
<property type="term" value="P:negative regulation of mucus secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060407">
<property type="term" value="P:negative regulation of penile erection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070244">
<property type="term" value="P:negative regulation of thymocyte apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048541">
<property type="term" value="P:Peyer's patch development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001890">
<property type="term" value="P:placenta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046638">
<property type="term" value="P:positive regulation of alpha-beta T cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030890">
<property type="term" value="P:positive regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050850">
<property type="term" value="P:positive regulation of calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002636">
<property type="term" value="P:positive regulation of germinal center formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010460">
<property type="term" value="P:positive regulation of heart rate"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045987">
<property type="term" value="P:positive regulation of smooth muscle contraction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033089">
<property type="term" value="P:positive regulation of T cell differentiation in thymus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050862">
<property type="term" value="P:positive regulation of T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032261">
<property type="term" value="P:purine nucleotide salvage"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009168">
<property type="term" value="P:purine ribonucleoside monophosphate biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0043101">
<property type="term" value="P:purine-containing compound salvage"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033632">
<property type="term" value="P:regulation of cell-cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042542">
<property type="term" value="P:response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043278">
<property type="term" value="P:response to morphine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033197">
<property type="term" value="P:response to vitamin E"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042110">
<property type="term" value="P:T cell activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001829">
<property type="term" value="P:trophectodermal cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046111">
<property type="term" value="P:xanthine biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd01320">
<property type="entry name" value="ADA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="HAMAP" id="MF_00540">
<property type="entry name" value="A_deaminase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR006650">
<property type="entry name" value="A/AMP_deam_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001365">
<property type="entry name" value="A/AMP_deaminase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR028893">
<property type="entry name" value="A_deaminase"/>
</dbReference>
<dbReference type="InterPro" id="IPR006330">
<property type="entry name" value="Ado/ade_deaminase"/>
</dbReference>
<dbReference type="InterPro" id="IPR032466">
<property type="entry name" value="Metal_Hydrolase"/>
</dbReference>
<dbReference type="Pfam" id="PF00962">
<property type="entry name" value="A_deaminase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51556">
<property type="entry name" value="SSF51556"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR01430">
<property type="entry name" value="aden_deam"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00485">
<property type="entry name" value="A_DEAMINASE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0360">Hereditary hemolytic anemia</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0546">Nucleotide metabolism</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0705">SCID</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="initiator methionine" description="Removed" evidence="36">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Adenosine deaminase" id="PRO_0000194352">
<location>
<begin position="2"/>
<end position="363"/>
</location>
</feature>
<feature type="region of interest" description="Required for binding to DDP4" evidence="11">
<location>
<begin position="126"/>
<end position="143"/>
</location>
</feature>
<feature type="active site" description="Proton donor" evidence="4">
<location>
<position position="217"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; catalytic" evidence="38">
<location>
<position position="15"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; catalytic" evidence="38">
<location>
<position position="17"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; catalytic" evidence="38">
<location>
<position position="214"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; catalytic" evidence="38">
<location>
<position position="295"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="1 35">
<location>
<position position="17"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="1 35">
<location>
<position position="19"/>
</location>
</feature>
<feature type="binding site" description="Substrate; via amide nitrogen" evidence="1 35">
<location>
<position position="184"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="1 35">
<location>
<position position="296"/>
</location>
</feature>
<feature type="site" description="Important for interaction with adenosine receptors and increasing their affinity for agonists" evidence="19">
<location>
<position position="58"/>
</location>
</feature>
<feature type="site" description="Important for interaction with adenosine receptors and increasing their affinity for agonists" evidence="19">
<location>
<position position="62"/>
</location>
</feature>
<feature type="site" description="Important for catalytic activity" evidence="4">
<location>
<position position="238"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="36">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="2">
<location>
<position position="54"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="2">
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; allele ADA*2; found in about 10% of the population; affects duration and intensity of deep sleep; enhances negative effects of sleep loss during sleep deprivation; may have a protective role against male infertility; 20% to 30% decrease in activity; dbSNP:rs73598374." id="VAR_002209" evidence="12 17 20 27">
<original>D</original>
<variation>N</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; loss of activity; dbSNP:rs121908725." id="VAR_002210" evidence="25">
<original>H</original>
<variation>D</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; loss of activity; dbSNP:rs121908724." id="VAR_002211" evidence="30">
<original>G</original>
<variation>R</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; delayed-onset; dbSNP:rs121908730." id="VAR_002212" evidence="6">
<original>G</original>
<variation>C</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908736." id="VAR_002213" evidence="16">
<original>R</original>
<variation>W</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11555566." id="VAR_002214" evidence="32">
<original>K</original>
<variation>R</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; loss of activity; dbSNP:rs121908726." id="VAR_002215" evidence="25">
<original>A</original>
<variation>D</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; unknown pathological significance; loss of activity on its own; total loss of activity; when associated with V-106; dbSNP:rs267606634." id="VAR_076954" evidence="34">
<original>Y</original>
<variation>C</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908714." id="VAR_002216" evidence="29">
<original>R</original>
<variation>L</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; loss of activity; dbSNP:rs121908714." id="VAR_002218" evidence="23">
<original>R</original>
<variation>Q</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908717." id="VAR_002217" evidence="22">
<original>R</original>
<variation>W</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; unknown pathological significance; 30% of activity; total loss of activity; when associated with C-97; dbSNP:rs267606635." id="VAR_076955" evidence="34">
<original>L</original>
<variation>V</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908739." id="VAR_002219" evidence="16">
<original>L</original>
<variation>P</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; delayed-onset; dbSNP:rs121908731." id="VAR_002220" evidence="6">
<original>V</original>
<variation>M</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908732." id="VAR_002221" evidence="6">
<original>G</original>
<variation>E</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In a pancreatic ductal adenocarcinoma sample; somatic mutation; dbSNP:rs61732239." id="VAR_002222" evidence="14 32">
<original>R</original>
<variation>Q</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908737." id="VAR_002223" evidence="16">
<original>R</original>
<variation>Q</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908733." id="VAR_002224" evidence="6">
<original>R</original>
<variation>W</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="sequence variant" description="In an individual with partial ADA deficiency but no immunodeficiency; 1,5% of activity; dbSNP:rs121908728." id="VAR_002225" evidence="33">
<original>L</original>
<variation>M</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908735." id="VAR_002226" evidence="9">
<original>R</original>
<variation>C</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; loss of activity; dbSNP:rs121908722." id="VAR_002227" evidence="29">
<original>R</original>
<variation>H</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; loss of activity; dbSNP:rs121908719." id="VAR_002228" evidence="29">
<original>V</original>
<variation>M</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; loss of activity; dbSNP:rs121908727." id="VAR_002229" evidence="25">
<original>A</original>
<variation>D</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; delayed-onset; dbSNP:rs121908734." id="VAR_002230" evidence="6">
<original>Q</original>
<variation>P</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; late onset; 4% of activity; dbSNP:rs121908740." id="VAR_002231" evidence="16 34">
<original>R</original>
<variation>C</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908716." id="VAR_002232" evidence="22">
<original>R</original>
<variation>H</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; 8% of activity; dbSNP:rs114025668." id="VAR_002233" evidence="16 34">
<original>A</original>
<variation>T</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; severe; dbSNP:rs121908723." id="VAR_002234" evidence="29">
<original>G</original>
<variation>R</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In an individual with partial ADA deficiency but no immunodeficiency; 20% of activity; dbSNP:rs121908729." id="VAR_002235" evidence="33 34">
<original>T</original>
<variation>I</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908738." id="VAR_002236" evidence="16">
<original>P</original>
<variation>L</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908721." id="VAR_002237" evidence="9 29">
<original>S</original>
<variation>L</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908718." id="VAR_002238" evidence="21">
<original>P</original>
<variation>Q</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; loss of activity; dbSNP:rs199422327." id="VAR_002239">
<original>L</original>
<variation>R</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID; dbSNP:rs121908715." id="VAR_002240" evidence="22">
<original>A</original>
<variation>V</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="sequence variant" description="In ADASCID." id="VAR_002241">
<location>
<position position="337"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases enzyme activity by reducing substrate affinity and maximum velocity; abolishes ADORA1 and ADORA2A modulator function." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately reduces enzyme activity; reduces ADORA1 and ADORA2A modulation." evidence="19">
<original>D</original>
<variation>A</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases enzyme activity by reducing maximum velocity; reduces ADORA1 modulation." evidence="19">
<original>F</original>
<variation>A</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases enzyme activity by reducing substrate affinity and maximum velocity; abolishes ADORA1 and ADORA2A modulator function." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately reduces enzyme activity; no change in ADORA1 and ADORA2A modulation." evidence="19">
<original>K</original>
<variation>A</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases enzyme activity by reducing substrate affinity and maximum velocity; reduces ADORA1 and ADORA2A modulation." evidence="19">
<original>F</original>
<variation>A</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in enzyme activity; no change in ADORA1 and ADORA2A modulation." evidence="19">
<original>D</original>
<variation>A</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases enzyme activity by reducing maximum velocity; reduces ADORA2A modulation." evidence="19">
<original>M</original>
<variation>A</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in enzyme activity; no change in ADORA1 and ADORA2A modulation." evidence="19">
<original>I</original>
<variation>A</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately reduces enzyme activity; no change in ADORA1 and ADORA2A modulation." evidence="19">
<original>N</original>
<variation>A</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases enzyme activity by reducing substrate affinity and maximum velocity." evidence="19">
<original>M</original>
<variation>A</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately reduces enzyme activity; no change in ADORA1 and ADORA2A modulation." evidence="19">
<original>H</original>
<variation>A</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately reduces enzyme activity." evidence="19">
<original>G</original>
<variation>Q</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately reduces enzyme activity." evidence="19">
<original>D</original>
<variation>A</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in enzyme activity." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAD97117." ref="5" evidence="37">
<original>K</original>
<variation>R</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="11"/>
<end position="13"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="18"/>
<end position="20"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="24"/>
<end position="34"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="43"/>
<end position="50"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="58"/>
<end position="62"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="63"/>
<end position="67"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="69"/>
<end position="72"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="76"/>
<end position="91"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="92"/>
<end position="94"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="95"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="104"/>
<end position="107"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="116"/>
<end position="118"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="126"/>
<end position="144"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="147"/>
<end position="155"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="162"/>
<end position="171"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="172"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="177"/>
<end position="184"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="191"/>
<end position="193"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="195"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="210"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="221"/>
<end position="229"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="234"/>
<end position="238"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="240"/>
<end position="244"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="246"/>
<end position="254"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="258"/>
<end position="261"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="263"/>
<end position="268"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="270"/>
<end position="272"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="279"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="290"/>
<end position="292"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="297"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="304"/>
<end position="315"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="319"/>
<end position="331"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="333"/>
<end position="335"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="337"/>
<end position="351"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="355"/>
<end position="362"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3IAR"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P03958"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P56658"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10200056"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10951221"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11772392"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1284479"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14691230"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15016824"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16221767"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16670267"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18772397"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20959412"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2166947"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21734253"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21919946"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23193172"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26166670"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2783588"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3182793"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3839802"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6208479"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7599635"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7907293"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8031011"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8101391"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8227344"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8299233"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8452534"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8589684"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9225964"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9361033"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source ref="24"/>
</evidence>
<evidence key="36" type="ECO:0000269">
<source ref="8"/>
</evidence>
<evidence key="37" type="ECO:0000305"/>
<evidence key="38" type="ECO:0000305">
<source ref="24"/>
</evidence>
<sequence length="363" mass="40764" checksum="786BC5085CA9AFCB" modified="2007-01-23" version="3">
MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPD
FLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQA
EGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAI
DLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGY
HTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIF
KSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAG
QNL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>